Fundraising for Findacure for Rare Disease Day 2021
As a CRO specialising in clinical trials for rare and orphan diseases, Rare Disease Day has become a special cause ...Read more >
News
Read our latest article - Rare disease clinical trials continue, thanks to new technology
Rare Disease Day offers a valuable opportunity to raise awareness of rare disease and campaign for health equity. We are ...Read more >
Simbec-Orion Streamlines Trial Execution With Veeva Clinical Applications
Vault CTMS and Vault eTMF provide complete visibility into trials, enabling CRO to deliver value-added services to sponsors PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva ...Read more >
Simbec-Orion and Oncodistinct Network agreement to strengthen early phase oncology research
Providing oncology drug developers with the successful delivery of early phase oncology studies Slough, Berkshire, United Kingdom: Simbec-Orion announced a ...Read more >
Exvastat wins a 3.6 million euro grant for COVID-19 trial
Congratulations to Cambridge Innovation Capital portfolio company Exvastat that has been awarded a grant from the prestigious Innovative Medicines Initiative. ...Read more >
Maintaining an agile and collaborative approach during the COVID-19 Pandemic
Simbec-Orion COVID-19 Update 1 April 2020
Lending a Hand to Support Rare Disease Day
As a CRO focusing on rare disease, we are delighted to support EURODIS’s 12th international Rare Disease Day. Taking inspiration from ...Read more >
Read The Latest Article, Engaging With Patients And Experts To Develop New Drugs
Dr Fabrice Chartier explains the complex nature of developing treatments for rare diseases. Read the article on page 17.
Simbec-Orion Receives The “CRO Of The Year” Award At 2019 European Lifestars AwardsTM
Celebrating success across life sciences London, UK, November 25th 2019. Simbec-Orion is pleased to announce that it has been recognised ...Read more >